Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boelaert

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Tropical Medicine & International Health : TM & IH|November 13, 2001
European Union's research policy: a moving target?M Boelaert, F Matthys, M Henkens, et al.
Tropical Medicine & International Health : TM & IH|October 1, 1998
Zidovudine to prevent mother-to-infant HIV transmission in developing countries: any questions?P Van der Stuyft, M Boelaert, M Temmerman
Bulletin of the World Health Organization|September 20, 2000
Through Mintzberg's glasses: a fresh look at the organization of ministries of healthJ P Unger, J Macq, F Bredo, et al.
Tropical Medicine & International Health : TM & IH|October 23, 2002
How better drugs could change kala-azar control. Lessons from a cost-effectiveness analysisM Boelaert, D Le Ray, P Van Der Stuyft
Tropical Medicine & International Health : TM & IH|February 29, 2008
Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, AngolaJ Robays, M E Raguenaud, T Josenando, et al.
Bulletin of the World Health Organization|October 12, 1999
Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasisM Boelaert, L Lynen, P Desjeux, et al.
Annales De La Societe Belge De Medecine Tropicale|June 1, 1995
[Surveillance of the nutritional status of the population in Kinshasa, Zaire (1991-1994)]M Arbyn, M Dedeurwaerder, M Miakala, et al.
The Lancet. Infectious Diseases|December 4, 2003
The challenge of Trypanosoma brucei gambiense sleeping sickness diagnosis outside AfricaV Lejon, M Boelaert, J Jannin, et al.
Nepal Medical College Journal : NMCJ|July 20, 2012
Will visceral leishmaniasis be eliminated from Nepal? A review of recent (1994-2006) control effortsG P Bhandari, M R Angdembe, S Rijal, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 13, 2006
The economic burden of visceral leishmaniasis for households in NepalS Rijal, S Koirala, P Van der Stuyft, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Tropical Medicine & International Health : TM & IH|November 13, 2001
European Union's research policy: a moving target?M Boelaert, F Matthys, M Henkens, et al.
Tropical Medicine & International Health : TM & IH|October 1, 1998
Zidovudine to prevent mother-to-infant HIV transmission in developing countries: any questions?P Van der Stuyft, M Boelaert, M Temmerman
Bulletin of the World Health Organization|September 20, 2000
Through Mintzberg's glasses: a fresh look at the organization of ministries of healthJ P Unger, J Macq, F Bredo, et al.
Tropical Medicine & International Health : TM & IH|October 23, 2002
How better drugs could change kala-azar control. Lessons from a cost-effectiveness analysisM Boelaert, D Le Ray, P Van Der Stuyft
Tropical Medicine & International Health : TM & IH|February 29, 2008
Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, AngolaJ Robays, M E Raguenaud, T Josenando, et al.
Bulletin of the World Health Organization|October 12, 1999
Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasisM Boelaert, L Lynen, P Desjeux, et al.
Annales De La Societe Belge De Medecine Tropicale|June 1, 1995
[Surveillance of the nutritional status of the population in Kinshasa, Zaire (1991-1994)]M Arbyn, M Dedeurwaerder, M Miakala, et al.
The Lancet. Infectious Diseases|December 4, 2003
The challenge of Trypanosoma brucei gambiense sleeping sickness diagnosis outside AfricaV Lejon, M Boelaert, J Jannin, et al.
Nepal Medical College Journal : NMCJ|July 20, 2012
Will visceral leishmaniasis be eliminated from Nepal? A review of recent (1994-2006) control effortsG P Bhandari, M R Angdembe, S Rijal, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 13, 2006
The economic burden of visceral leishmaniasis for households in NepalS Rijal, S Koirala, P Van der Stuyft, et al.
Pageof 9